S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q1 2024

Deep Track Capital

Period: Q1 2024 Β· Filed: 2024-05-15
View on SEC EDGAR β†—
AUM
$3.49B
Total portfolio value
Positions
66
Reported securities
Top Holding
SWTX
4.9% $171.3M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-05-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
SWTXSPRINGWORKS THERAPEUTICS INC$171.3M4.91%β€”β€”
4.9%
AMGNAMGEN INC$156.4M4.48%$264.32$374.15+41.5%
4.5%
APGEAPOGEE THERAPEUTICS INC$154.4M4.42%$65.05$132.91+104.3%
4.4%
INSMINSMED INC$129.8M3.72%$26.72$111.60+317.7%
3.7%
DYNDYNE THERAPEUTICS INC$129.3M3.70%$28.00$23.07-17.6%
3.7%
ALNYALNYLAM PHARMACEUTICALS INC$124.4M3.56%$153.33$312.78+104.0%
3.6%
GHGUARDANT HEALTH INC$123.8M3.55%$20.25$167.98+729.5%
3.5%
ARGXARGENX SE$118.1M3.38%$397.33$939.68+136.5%
3.4%
NTLAINTELLIA THERAPEUTICS INC$115.8M3.32%$27.22$17.56-35.5%
3.3%
OCULOCULAR THERAPEUTIX INC$115.8M3.32%$8.69$9.64+10.9%
3.3%
DVAXDYNAVAX TECHNOLOGIES CORP$113.5M3.25%β€”β€”
3.3%
AXSMAXSOME THERAPEUTICS INC$104.1M2.98%$76.99$244.31+217.3%
3.0%
ITCIINTRA-CELLULAR THERAPIES INC$103.8M2.97%β€”β€”
3.0%
GERNGERON CORP$100.7M2.88%$3.17$1.36-57.1%
2.9%
AUTLAUTOLUS THERAPEUTICS PLC$97.4M2.79%$5.68$1.58-72.2%
2.8%
FDMT4D MOLECULAR THERAPEUTICS IN$96.7M2.77%$30.01$13.00-56.7%
2.8%
ALKSALKERMES PLC$94.7M2.71%$27.24$54.58+100.4%
2.7%
BCYCBICYCLE THERAPEUTICS PLC$86.9M2.49%$24.25$4.35-82.1%
2.5%
PLRXPLIANT THERAPEUTICS INC$85.7M2.45%$14.81$1.17-92.1%
2.5%
MNMDMIND MEDICINE MINDMED INC$62.7M1.80%β€”β€”
1.8%
ABVXABIVAX SA$61.5M1.76%$13.97$144.65+935.4%
1.8%
VRDNVIRIDIAN THERAPEUTICS INC$60.5M1.73%$17.26$19.40+12.4%
1.7%
IONSIONIS PHARMACEUTICALS INC$59.5M1.71%$43.94$81.80+86.2%
1.7%
APLSAPELLIS PHARMACEUTICALS INC$58.8M1.68%$59.71β€”
1.7%
ANIPANI PHARMACEUTICALS INC$56.8M1.63%$67.87$86.03+26.8%
1.6%
TVTXTRAVERE THERAPEUTICS INC$56.8M1.63%$7.31$56.92+678.7%
1.6%
VRNAVERONA PHARMA PLC$51.3M1.47%β€”β€”
1.5%
KYMRKYMERA THERAPEUTICS INC$50.7M1.45%$39.42$113.51+187.9%
1.4%
IVVDINVIVYD INC$48.6M1.39%$4.25$0.89-79.1%
1.4%
SYRESPYRE THERAPEUTICS INC$46.0M1.32%$37.00$86.63+134.1%
1.3%

Quarter-on-Quarter Activity

Q1 2024 vs. Q4 2023

New Positions (8)

TickerIssuerNotionalSince Filing
AMGNAMGEN INC$156.4M+41.5%
ALNYALNYLAM PHARMACEUTICALS INC$124.4M+104.0%
MNMDMIND MEDICINE MINDMED INC$62.7M
APLSAPELLIS PHARMACEUTICALS INC$58.8M
KYMRKYMERA THERAPEUTICS INC$50.7M+187.9%
IVVDINVIVYD INC$48.6M-79.1%
FATEFATE THERAPEUTICS INC$40.9M
ENGNENGENE HOLDINGS INC$38.1M

Exited Positions (8)

TickerIssuerNotional
CYTKCYTOKINETICS INC$112.5M
AMAMAMBRX BIOPHARMA INC$52.8M
SRPTSAREPTA THERAPEUTICS INC$48.2M
RAPTRAPT THERAPEUTICS INC$44.6M
ACLXARCELLX INC$40.3M
ORTXORCHARD THERAPEUTICS PLC$33.6M
EWTXEDGEWISE THERAPEUTICS INC$27.8M
CYTKCYTOKINETICS INC$24.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
DYNDYNE THERAPEUTICS INC$102.7M+127.8%-17.6%
ALLKALLAKOS INC$-0.6M+99.1%
NTLAINTELLIA THERAPEUTICS INC$47.2M+87.1%-35.5%
OLMAOLEMA PHARMACEUTICALS INC$9.4M+67.0%
OCULOCULAR THERAPEUTIX INC$74.6M+37.8%+10.9%
ANIPANI PHARMACEUTICALS INC$23.7M+37.0%+26.8%
FDMT4D MOLECULAR THERAPEUTICS IN$50.4M+32.8%-56.7%
AXSMAXSOME THERAPEUTICS INC$24.5M+30.5%+217.3%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
ITCIPUTINTRA-CELLULAR THERAPIES INC$-131.1M-91.2%
GPCRSTRUCTURE THERAPEUTICS INC$-10.5M-86.6%
ANABANAPTYSBIO INC$-31.7M-74.0%
IMVTIMMUNOVANT INC$-26.2M-50.7%
RLMDRELMADA THERAPEUTICS INC$-2.7M-39.3%
NUVLNUVALENT INC$-12.5M-39.0%
SYRESPYRE THERAPEUTICS INC$4.0M-37.9%+134.1%
SRRKSCHOLAR ROCK HLDG CORP$-7.0M-32.8%
← Back to Hedge Funds